2018 CNS Annual Meeting Scientific Program Committee Chair, Dr. Erika Augustine, previews this year’s curriculum and focus in conversation with Dr. David Urion
David Urion, MD, FAAN
David Urion serves as the program director for the Child Neurology and Neurodevelopmental Disabilities residencies at Boston Children’s Hospital, where he holds the Charles F. Barlow Chair in the Department of Neurology, an endowed chair devoted to medical education. He is the immediate Past President of the Professors of Child Neurology (PCN). He has been involved in the Universal Curriculum initiative, served on the ACGME Neurology RRC working group developing the Child Neurology Milestones, chaired the Working Group for the NDD Milestones, and serves on the Working group for Child Neurology Milestones 2.0. He is on the Neurology Residency Review Committee of the ACGME. In the AAN, he serves on the Graduate Education Subcommittee, the RITE examination advisory committee (where he leads the Child Neurology section). He writes the neurology section of AAP Grand Rounds, and serves on the executive committee of the AAP Section on Neurology, where is liaison to the Government and Regulatory Affairs Committee.
Dr. Urion directs the Behavioral Neurology Clinics and Programs at Boston Children’s Hospital. He has been awarded the Teacher of the Year award three times by the Child Neurology residents at Boston Children’s Hospital. He is also a medical ethicist, and is Co-Chair of the Ethics Advisory Committee at Boston Children’s Hospital. He teaches ethics classes at Harvard Medical School, and is course co-director for the ethics module of Essentials of the Profession course, which all students take after their principle clinical experience (core rotations).
Dr. Urion is the recipient of the 2016 CNS/PCN Blue Bird Circle Training Program Director Award
Erika Augustine, MD
Erika F. Augsutine, MD is Senior Instructor of Neurology and Pediatrics at the University of Rochester Medical Center. She completed undergraduate studies at Harvard College and received her M.D. degree from the University of Rochester. Dr. Augustine completed Pediatrics and Child Neurology residency training at Children’s Hospital Boston in 2008, followed by fellowship training in Pediatric Movement Disorders and Experimental Therapeutics in 2010 at the University of Rochester. Dr. Augustine’s research interests include methodology of clinical research and experimental therapeutics in rare pediatric neurological disorders. Current work focuses on therapeutics in Juvenile Neuronal Ceroid Lipofuscinosis and on the epidemiology of Tourette Syndrome in minorities. She currently serves as Assistant Program Director for the NINDS-funded Experimental Therapeutics training program at the University of Rochester. She is also a member of the NIH Taskforce on Childhood Motor Disorders and is a consultant to the FDA Neurological Devices Panel